Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Madison Vaccines

Request full access

Madison Vaccines Incorporated develops vaccines for patients with prostate cancer and a test to identify such patients

Menomonie, United StatesFounded 2012Biotech & Life Sciences

About Madison Vaccines

Madison Vaccines, Inc. (MVI) is a biotechnology company focused on developing advanced immunotherapies for prostate cancer. The company specializes in DNA plasmid immunotherapies and combination therapies designed to improve the effectiveness of existing treatments and delay disease progression. MVI serves a diverse range of clients including patients, clinicians, and pharmaceutical partners. Operating in the oncology market, MVI aims to provide innovative solutions that enhance the quality of life for men battling prostate cancer.

MVI's business model revolves around the development and clinical testing of their proprietary immunotherapies. They generate revenue through partnerships with pharmaceutical companies, clinical trials, and potentially through the commercialization of their therapies. By combining their immunotherapies with PD-1 inhibitors and AR axis inhibitors, MVI aims to maximize the clinical value of standard care therapies and drive their adoption in the medical community.

The company is committed to aggressive research and development, ensuring that their therapies are safe and effective for patients at all stages of prostate cancer. MVI's innovative approach not only focuses on treating the disease but also on preserving the quality of life for patients.

Source: Dealroom company data

Madison Vaccines in the Menomonie ecosystem

Live from Dealroom

The Madison Vaccines office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • Venture Investors Health Fund
  • WARF Ventures
  • Investment Partners
  • State of Wisconsin Investment Board
  • Venture Management
  • Wisconsin Investment Partners
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Menomonie HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Madison Vaccines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Madison Vaccines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.